News Search Results
Apr 29, 2025, 13:10 ET Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer
Transneural Therapeutics, Inc. (Transneural), a preclinical-stage biotechnology company aiming to transform the treatment of neuropsychiatric and neurodegenerative diseases with novel neuroplastogens, announced the appointment
More news about: Transneural Therapeutics, Inc.
Apr 29, 2025, 12:50 ET Hydrocolloids Market Set to Reach $10.42 Billion by 2029 - Growth Driven by Innovations in Food & Pharmaceuticals | Valuates Reports
vegan-friendly ingredients has led to a rise in agar applications in confectionery, bakery, and dessert sectors. Additionally, the pharmaceutical and biotechnology sectors utilize agar for microbial culture media preparation. The natural origin of carrageenan and agar also aligns well with the clean-label movement
More news about: Valuates Reports
Apr 29, 2025, 11:15 ET Marengo Presents Expanded Clinical Monotherapy Activity of Invikafusp Alfa in Multiple PD-1 Resistant Tumors as a Clinical Plenary Oral at AACR 2025
April 29, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy, today announced new clinical and translational data from the ongoing STARt-001
More news about: Marengo Therapeutics
Apr 29, 2025, 10:10 ET Hoofprint Biome Raises $15M to Cut Methane and Boost Yield in Cattle
the rumen, and it's natural?" "Nature has spent millions of years evolving proteins as tools to regulate microbial growth. Biotechnology and artificial intelligence have finally gotten to the point where we can actually turn nature's tools into viable commercial products," says
More news about: Hoofprint Biome
Apr 29, 2025, 10:07 ET Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow
a range of cell types, payloads, and therapeutic applications. Kytopen has recently disclosed strategic partnerships with industry-leading biotechnology companies, contract development and manufacturing organizations (CDMOs), and cell therapy-focused medical centers. Kytopen continues to engage strategic
More news about: Kytopen
Apr 29, 2025, 10:05 ET Active Pharmaceutical Ingredients (API) Market to Amass $359.45 Billion by 2030 at CAGR 5.85% - Grand View Research, Inc.
projected to grow at a CAGR of 4.7% from 2024 to 2030. This growth is attributed to the increasing demand for innovative medicines, advancements in biotechnology, and the shift towards microbial-based fermentation approaches. In addition, the rising need for environmentally friendly production methods and
More news about: Grand View Research, Inc.
Apr 29, 2025, 09:30 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sana Biotechnology, Inc. ("Sana" or "the Company") (NASDAQ:
More news about: The Schall Law Firm
Apr 29, 2025, 09:30 ET Appian Celebrates 2025 Innovation Award Winners
Regeneron: A leading biotechnology firm has created a cutting-edge clinical trial feasibility platform. Using multiple Appian capabilities, this technology delivers an innovative
More news about: Appian
Apr 29, 2025, 09:30 ET Appian Celebrates 2025 Innovation Award Winners
Regeneron: A leading biotechnology firm has created a cutting-edge clinical trial feasibility platform. Using multiple Appian capabilities, this technology delivers an innovative
More news about: Appian
Apr 29, 2025, 09:00 ET Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 29, 2025 /PRNewswire/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced the completion of ISO 10993 biocompatibility testing and human skin safety
More news about: Spiderwort Biotechnologies Inc.
Apr 29, 2025, 09:00 ET Gifthealth Appoints Chip Parkinson as Chief Executive Officer to Accelerate Growth and Innovation in Pharmacy Services
Chief Executive Officer. A veteran healthcare executive with three decades of experience, Parkinson brings deep leadership expertise across biotechnology, pharmacy benefit management, diagnostics, and pharmaceutical industries. His extensive background includes spearheading billion-dollar portfolios
More news about: Gifthealth
Apr 29, 2025, 09:00 ET Over 400 Leaders from More Than 50 Countries/Territories Attend World Trade Centers Association's 55th Annual Global Business Forum in Marseille, France
Africa, and Middle Eastern markets; the city's wide range of thriving industries, from maritime and logistics, to digital technology and biotechnology; and its ongoing infrastructure investments. Select WTC businesses also participated in the "Connections Showcase" to formally acknowledge the meaningful
More news about: World Trade Centers Association
Apr 29, 2025, 09:00 ET Over 400 Leaders from More Than 50 Countries/Territories Attend World Trade Centers Association's 55th Annual Global Business Forum in Marseille, France
Africa, and Middle Eastern markets; the city's wide range of thriving industries, from maritime and logistics, to digital technology and biotechnology; and its ongoing infrastructure investments. Select WTC businesses also participated in the "Connections Showcase" to formally acknowledge the meaningful
More news about: World Trade Centers Association
Apr 29, 2025, 08:43 ET Chiller Body Accepted into UF Innovate | Accelerate at The Hub to Drive Global Expansion of its Patented Cooling Hat Inserts
UF Innovate | Accelerate is an overarching entrepreneurship support program that includes Sid Martin Biotech, the globally recognized biotechnology incubator headquartered in Alachua, Florida, at Progress Park, and The Hub, the award-winning mixed-used incubator
More news about: Chiller Body, LLC
Apr 29, 2025, 08:34 ET AlphaRose Therapeutics Announces Acquisition of Alpha Anomeric SA, a French Company with Industry-Leading Oligonucleotide Technology
April 29, 2025 /PRNewswire/ -- AlphaRose Therapeutics, an advanced preclinical-stage biotechnology company focused on developing and commercializing therapeutics for neurogenetic developmental diseases, today announces the acquisition of Alpha
More news about: AlphaRose Therapeutics
Apr 29, 2025, 08:24 ET Tavo Biotherapeutics Announces Appointment of Seasoned Executives to Key Posts
Development Officer, and Graham Cooper as Chief Financial Officer. Both bring proven track records of success in the biotechnology industry. "I am thrilled to bring on Lukas and Graham to Tavo's senior team," said Gary Berman, Chief Executive
More news about: Tavo Biotherapeutics
Apr 29, 2025, 08:05 ET INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025
MEETING, Pa., April 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Apr 29, 2025, 08:05 ET Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update
via the Rigel website. About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.
Apr 29, 2025, 08:02 ET GreenLight Biosciences Announces Breakthrough in RNA Herbicide Development, Advancing More Sustainable Weed Control
April 29, 2025 /PRNewswire/ -- GreenLight Biosciences (the Company or GreenLight Bio), a pioneering agricultural biotechnology company, today announced a significant breakthrough in its bioherbicide development pipeline.
More news about: GreenLight Biosciences
Apr 29, 2025, 08:00 ET Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics
physician-scientist with nearly 20 years of professional experience founding and building biotechnology companies and practicing medicine. Previously, he served as President and CEO of Tome Biosciences, a genome engineering biotechnology platform company. Prior to Tome, Dr. Kakkar was CEO at Pandion Therapeutics,
More news about: Flagship Pioneering
Apr 29, 2025, 08:00 ET Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025
Mass., April 29, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company
More news about: Curis, Inc.
Apr 29, 2025, 07:30 ET Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
Total stockholder returns of 267% over the past five years: Far exceeding the performance of the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index1.Highly successful commercialization of HEPLISAV-B®: Generated
More news about: Dynavax Technologies
Apr 29, 2025, 07:30 ET Palatin Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Apr 29, 2025, 07:00 ET ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
MB-105, the progress of clinical trials for pipeline candidates, regulatory approvals, market demand for new therapies, competitive dynamics in the biotechnology sector, and macroeconomic conditions.
More news about: Bio-Techne Corporation
Apr 29, 2025, 06:15 ET Epson Advances SCARA Performance with New GX-C Series Robots
of experience, Epson Robots delivers robots for precision assembly and material handling applications in the aerospace, appliance, automotive, biotechnology, consumer product, electronics, food processing, medical device, pharmaceutical, plastics, semiconductor, and telecommunication industries. For
More news about: Epson America, Inc.